Warfarin-induced calciphylaxis successfully treated with sodium thiosulphate

Australasian Journal of Dermatology

Volumn 54, Issue 2, 2013, Pages 133-135

  Hafiji, Juber ^a   Deegan, Patrick ^b   Brais, Rebecca ^b   Norris, Paul ^b  

^a Skin Cancer Institute   (New Zealand)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

calciphylaxis; sodium thiosulphate; vitamin K2; warfarin

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; DOXYCYCLINE; ENOXAPARIN; OPIATE; SODIUM THIOSULFATE; WARFARIN;

ADULT; ANALGESIA; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTICLE; BRONCHIECTASIS; CASE REPORT; DEBRIDEMENT; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FAT NECROSIS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEG PAIN; LEG ULCER; MAGGOT THERAPY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; SKIN BIOPSY; TREATMENT DURATION; ULCER HEALING;

ANTICOAGULANTS; ANTIOXIDANTS; CALCIPHYLAXIS; DRUG ERUPTIONS; HUMANS; MALE; MIDDLE AGED; SKIN ULCER; THIOSULFATES; WARFARIN;

EID: 84876282650     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2011.00861.x     Document Type: Article

References (13)

1. Asobie N, Wong E, Cook MG,. Calciphylaxis in a diabetic patient provoked by warfarin therapy. Clin. Exp. Dermatol. 2008; 33: 342-44.
2. Bolognia JL, Jorizzo JL, Rapini RP, (eds). Dermatology. St Louis, MO: Mosby Year Book, 2008; 654-5.
3. Weenig RH, Sewell LD, Davis MD, et al,. Calciphylaxis: natural history, risk factor analysis, and outcome. J. Am. Acad. Dermatol. 2007; 56: 569-79.
4. Seyle H, Gabbiani G, Strebel R,. Sensitisation to calciphylaxis by endogenous parathyroid hormone. Endocrinology 1962; 71: 554-8.
5. Kalajian AH, Malhotra PS, Callen JP, et al,. Calciphylaxis with normal renal and parathyroid function. Arch. Dermatol. 2009; 145: 451-8.
6. Price PA, Faus SA, Williamson MK,. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 1400-7.
7. Abdul-Jabar HB, Geroulakos G, Philpott N, et al,. Warfarin-induced skin necrosis: a case report. Clin. Appl. Thromb. Hemost. 2006; 12: 101-4.
8. Parsi K, Younger I, Gallo J,. Warfarin-induced skin necrosis associated with acquired protein C deficiency. Australas. J. Dermatol. 2003; 44: 57-61.
9. Sallah S, Abdallah JM, Gagnon GA,. Recurrent warfarin-induced skin necrosis in kindreds with protein S deficiency. Haemostasis 1998; 2: 25-30.
10. Baker BL, Fitzgibbons CA, Buescher LS,. Calciphylaxis responding to sodium thiosulphate therapy. Arch. Dermatol. 2007; 143: 269-70.
11. Wilmer WA, Magro CM,. Calciphylaxis: emerging concepts in prevention, diagnosis and treatment. Semin. Dial. 2002; 15: 172-86.
12. Schurgers LJ, Spronk HM, Soute BA, et al,. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007; 109: 2823-31.
13. Conly J, Stein K,. Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin. Invest. Med. 1994; 17: 531-9.